Experience with monthly, high-dose, intravenous immunoglobulin therapy in patients with different connective tissue diseases

Rheumatology International

Volumn 25, Issue 3, 2005, Pages 211-214

  Kamali, Sevil ^a   Cefle, Ayse ^a   Sayarlioglu, Mehmet ^a   Gul, Ahmet ^a   Inanc, Murat ^a   Ocal, Lale ^a   Aral, Orhan ^a   Konice, Meral ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Inflammatory muscle disease; Intravenous immunoglobulin; Wegener's granulomatosis

Indexed keywords

IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; CONNECTIVE TISSUE DISEASE; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; FEVER; HUMAN; INFLAMMATORY MUSCLE DISEASE; MALE; MUSCLE DISEASE; MYCOBACTERIUM; PRIORITY JOURNAL; SCHOOL CHILD; SCORING SYSTEM; SIDE EFFECT; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS; WEGENER GRANULOMATOSIS; AGE; AGED; CHILD; COHORT ANALYSIS; COMPARATIVE STUDY; DRUG ADMINISTRATION; FOLLOW UP; MIDDLE AGED; MORTALITY; MYOSITIS; PATHOLOGY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; COHORT STUDIES; CONNECTIVE TISSUE DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MYOSITIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; WEGENER GRANULOMATOSIS;

EID: 17744388323     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-003-0422-0     Document Type: Article

References (33)

1. Imbach P, Wagner H, Berchtold W et al (1985) Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood. Lancet 2:464
2. Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J et al (1991) A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324:1633-1639
3. Lang BA, Laxer RM, Murphy G, Silverman ED, Roifman CM (1991) Treatment of dermatomyositis with intravenous gammaglobulin. Am J Med 91:169-172
4. Dalakas MC (1991) Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 325:1487-1498
5. Choy EH, Isenberg DA (2002) Treatment of dermatomyositis and polymyositis. Rheumatology 411:7-13
6. Cherin P, Pelletier S, Teixeira A, Laforet P, Genereau T, Simon A, Maisonobe T, Eymard B, Herson S (2002) Results and long-term follow-up of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients. Arthritis Rheum 46:467-474
7. Collet E, Dalac S, Maerens B, Courtois JM, Izac M, Lambert D (191994) Juvenile dermatomyositis: treatment with intravenous gammaglobulin. Br J Dermatol 130:231-234
8. Levy Y, Sherer Y, Ahmed A, Langevitz P, George J et al (1999) A study of 20 patients with intravenous immunoglobulin - clinical and serologic response. Lupus 8:705-712
9. Levy Y, Sherer Y, George J, Rovensky J, Lukac J et al (2000) Intravenous immunoglobulin treatment of lupus nephritis. Semin Arthritis Rheum 29:321-327
10. Palla R, Cirami C, Bionda A et al (1986) High dose intravenous gammaglobulin for membranous nephropathy. Clin Nephrol 26:314
11. Boletis JN, Ioannidis JPA, Boki KA, Moutsopoulos HM (1999) Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis. Lancet 354:569-570
12. Carreras LO, Perez GN, Vega HR, Casavilla F (1988) Lupus anticoagulant and recurrent fatal loss: successful treatment with gammaglobulin. Lancet 2:393-394
13. Sherer Y, Levy Y, Shoenfeld Y (2000) Intravenous immunoglobulin therapy of antiphospholipid syndrome. Rheumatology 39:421-426
14. Branch D, Ware MD, Peaceman AM et al (2000) A multicenter, placebo controlled pilot study of intravenous treatment of antiphospholipid syndrome during pregnancy. Am J Obstet Gynecol 182:122-127
15. Jayne DRW, Lockwood CM (1996) Intravenous immunoglobulin as sole therapy for systemic vasculitis. Br J Rheumatol 35:1150-1153
16. Jayne DRW, Chapel H, Adu D, Misbah S, O'Donoghue D, Scott D (2000) Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. QJM 93:433-49
17. Permal S, Wechsler B, Cabane J, Perrot S, Blum L, Imbert JC (1995) Treatment of Still disease in adults with intravenous immunoglobulins. Rev Med Interne 16:250-254
18. Kazatchkine MD, Kaveri SV (2001) Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 345:747-755
19. Tan EM (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277
20. Leavitt RY et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 33:1101-1107
21. Dalakas MC (1988) A classification of polymyositis and dermatomyositis. In: Dalakas MC (ed) Polymyositis and dermatomyositis. Butterworth, Boston, pp 1-16
22. Pyne D, Ehrenstein M, Morris V (2002) The therapeutic uses of intravenous immunoglobulins in autoimmune rheumatic diseases. Rheumatology 41:367-374
23. Maier WP, Gordon DS, Howard RF, Saleh MN, Miller SB et al (1990) Intravenous immunoglobulin therapy in systemic lupus erythematosus-associated thrombocytopenia. Arthritis Rheum 33:1233-1239
24. Jacobs P, Wood L (1989) The comparison of gammaglobulin to steroids in treating adult immune thrombocytopenia: an interim analysis. Blut 59:92-95
25. Sherer Y, Levy Y, Langevitz P, Lorber M, Fabrizzi F, Shoenfeld Y (1999) Successful treatment of systemic lupus erythematosus cerebritis with intravenous immunoglobulin. Clin Rheumatol 18:170-173
26. Lafferty TE, Smith JB, Schuster SJ, De Horatius RJ (1997) Treatment of acquired factor VIII inhibitor using intravenous immunoglobulin in two patients with systemic lupus erythematosus. Arthritis Rheum 40:775-778
27. Aharon A, Levy Y, Bar-Dayan Y, Afek A, Zandman-Goddard G, Skurnik Y, Fabrizzi F, Shoenfeld Y (1997) Successful treatment of early secondary myelofibrosis in SLE with IVIG. Lupus 6:408-411
28. Kurth R, Haas WH (2002) Epidemiology, diagnostic possibilities, and treatment of tuberculosis. Ann Rheum Dis 61 [Suppl 2]:ii59-ii61
29. Dalakas MC (1998) Controlled studies with high-dose intravenous immunoglobulin in the treatment of dermatomyositis, inclusion body myositis, and polymyositis. Neurology 51 [6 Suppl 5]:S37-S45
30. Hamilos DL, Christensen J (1991) Treatment of Churg-Strauss syndrome with high-dose intravenous immunoglobulin. J Allergy Clin Immunol 88:823-824
31. Levy Y, Sherer Y, George J, Langevitz P, Ahmed A, Bar-Dayan Y, Fabrizzi F, Terryberry J, Peter J, Shoenfeld Y (1999) Serologic and clinical response to treatment of systemic vasculitis and associated autoimmune disease with intravenous immunoglobulin. Int Arch Allergy Immunol 119:231-238
32. Epstein JS, Gaines A, Kapit R, Pierce R, Potter R, Varricchio F (1999) Important drug information: immune globulin intravenous (human). Int J Trauma Nurs 5:139-140
33. Hashkes PJ, Lovell DJ (1996) Vasculitis in systemic lupus erythematosus following intravenous immunoglobulin therapy. Clin Exp Rheumatol 14:673-675